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Lamina-associated polypeptides (LAPs) are im-
portant components of the nuclear lamina, the
dense network of filaments that supports the
nuclear envelope and also extends into the nu-
cleoplasm. The main protein constituents of the
nuclear lamina are the constitutively expressed
B-type lamins and the developmentally regu-
lated A- and C-type lamins. LAP2a is the only
non-membrane-associated member of the LAP
family. Itpreferentiallybinds laminA/C,hasbeen
implicated in cell-cycle regulation and chroma-
tin organization, and has also been found to be
a component of retroviral preintegration com-
plexes. As an approach to understanding the
role of LAP2a in cellular pathways, we have de-
termined the crystal structure of the C-terminal
domain of LAP2a, residues 459–693. The C-ter-
minal domain is dimeric and possesses an ex-
tensive four-stranded, antiparallel coiled coil.
The surface involved in binding laminA/C is pro-
posed based on results from alanine-scanning
mutagenesis and a solid-phase overlay binding
assay.
INTRODUCTION
Mammalian nuclei are bounded by two lipid bilayers, the
outer and inner membranes. The inner membrane is sup-
ported by a thin web of proteins known as the nuclear
lamina, assembled from intermediate filaments 10 nm in
diameter that extend throughout the nucleus. The funda-
mental building blocks of these filaments are the A- and
B-type lamins. Lamin proteins contain a long, central a-
helical rod domain through which monomers associate
to form coiled-coil dimers; these, in turn, can polymerize in
a head-to-tail fashion and associate laterally to form rigid
filaments. One gene, LMNA, encodes the four vertebrateStructure 15,A- andC-type lamins that are the result of alternative splic-
ing (Figure 1A). Two other genes, LMNB1 and LMNB2,
encode lamins B1 and B2 (and its splice variant, B3), the
other major constituents of the nuclear lamina. The
B-type lamins are expressed in most cells and are essen-
tial for cell survival and normal development. In contrast,
the A-type lamins are differentially expressed, and their
more subtle role in nuclear function is highlighted by the
observation that LMNA/ mice survive gestation, but
die a few weeks after birth (Sullivan et al., 1999).
Mutations in LMNA give rise to a range of human dis-
eases known collectively as laminopathies (reviewed in
Broers et al., 2006; Capell and Collins, 2006). These vary
from tissue-specific diseases such as striated muscular
dystrophies or adipose tissue lipodystrophies to systemic
diseases such as Hutchinson-Gilford progeria syndrome
(HGPS), which causes premature aging in children. To
date, over 200 different disease-causing mutations, scat-
tered throughout the gene, have been identified in LMNA.
Lamins serve as crucial architectural components and
organizers of nuclear structure by virtue of their ability to
interact with other proteins: for example, binding of lamins
to integral membrane proteins tethers the nuclear lamina
to the inner nuclear membrane, and interactions between
lamins and DNA-binding proteins anchor lamins to chro-
matin. One important group of lamin-binding proteins is
comprised of the lamina-associated polypeptides (LAPs).
The three isoforms of LAP1 (1A, 1B, and 1C) bind prefer-
entially to A-type lamins, whereas four of the LAP2 iso-
forms (b, 3, d, and g) bind preferentially to the inner mem-
brane-associated B-type lamins. LAP2a, the largest LAP2
isoform, is a 693 residue protein and an atypical member
of the family, as it is not membrane associated, is localized
throughout the nucleus (Dechat et al., 1998), and has only
its N-terminal 186 amino acids in common with the other
LAP2 isoforms (Figure 1B). The N-terminal ‘‘constant re-
gion’’ contains a LEM domain (LAP2, emerin, and MAN1)
(Lin et al., 2000). The solution structure of the constant re-
gion of human LAP2 reveals that it consists of an N-termi-
nal LEM-like domain linked through a flexible tether to the
LEM domain (Cai et al., 2001); the structures of the iso-
lated domains have also been determined (Laguri et al.,643–653, June 2007 ª2007 Elsevier Ltd All rights reserved 643
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Structure of the C-Terminal Domain of LAP2a2001). Whereas the N-terminal constant region of LAP2a
is monomeric, the full-length protein has been reported
to be an oligomer (Snyers et al., 2007).
Many of the established functions of LAP2a map to its
unique C-terminal region. For example, the C terminus
of LAP2a is responsible for its retention in postmitotic nu-
clei, a process that is likely mediated through binding to
chromosomal proteins rather than direct interactions
with DNA (Dechat et al., 1998; Vlcek et al., 1999, and ref-
erences therein). Deletion analysis has indicated that the
extreme C terminus of LAP2a, residues 616–693, binds
specifically to residues 319–572 of lamin A/C (Dechat
et al., 2000). The importance of this interaction is sug-
gested by the results of a genetic screen in patients and
families with dilated cardiomyopathy that identified a sin-
gle point mutation at the C terminus of LAP2a, R690C, in
one pedigree (Taylor et al., 2005). In vitro, this mutant ver-
Figure 1. The Modular Organization of Lamin A/C and LAP2
Isoforms
(A) Schematic representation of the four mammalian lamin A/C iso-
forms obtained from alternative splicing of the LMNA gene. The central
coiled-coil region, consisting of 350 residues, is predicted to contain
four separate domains, designated 1A, 1B, 2A, and 2B; these are
shown in light blue. The intervening gray regions correspond to linker
regions L1, L12, and L2. Structures of part of the 2B coiled coil (PDB
code 1x8y, [Strelkov et al., 2004]) and the immunoglobulin-like domain
shown in orange (PDB code 1ifr, [Dhe-Paganon et al., 2002]; PDB code
1ivt, [Krimm et al., 2002]) have been determined. Also shown is the re-
gion corresponding to the lamin A/C (305–547) construct used in solid-
phase overlay binding studies with LAP2a (see Experimental Proce-
dures). The accession codes are NP_733821 (Homo sapiens lamin
A), NP_733822 (Homo sapiens lamin AD10), NP_005563 (Homo sapi-
ens lamin C), and BAA03578 (Mus musculus lamin C2).
(B) Schematic representation of the six mouse LAP2 isoforms (Berger
et al., 1996). The constant region (residues 1–186) consists of a LEM-
like domain (residues 1–50) connected by a flexible tether to a LEM do-
main between residues 111 and 153 (Cai et al., 2001). The C-terminal
region unique to LAP2a is shown in green. It contains at least one
independently folding domain, residues 459–693 (this work); this con-
tains the amino acids required for lamin A/C binding (Dechat et al.,
2000), shown in dark green.644 Structure 15, 643–653, June 2007 ª2007 Elsevier Ltd All rigsion of LAP2a is reported to be significantly impaired in its
ability to bind lamin A. In addition, LAP2a has been dem-
onstrated to bind to the retinablastoma protein, pRb (Mar-
kiewicz et al., 2002). Through this interaction mediated by
LAP2a residues 415–615, LAP2a-lamin A/C complexes
have been shown to affect cell-cycle progression and to
influence the balance between cell proliferation and differ-
entiation (Dorner et al., 2006).
LAP2a, but not the other LAP2 isoforms, has been iden-
tified as a cellular component of retroviral preintegration
complexes (PICs) (Suzuki et al., 2004). Although the extent
of LAP2a’s role in the retroviral lifecycle is not yet clear, it
has been shown that the replication of murine leukemia
virus (MLV) is inhibited in LAP2a knockdown cells (Suzuki
et al., 2004). It has also been shown that LAP2 isoforms
can bind to another host-cell protein found in PICs, the
barrier-to-autointegration (BAF) protein (Furukawa, 1999;
Shumaker et al., 2001). This interaction is mediated
through the LEM domain shared by all LAP2 isoforms.
As an approach to understanding the roles that LAP2a
plays in nuclear structure and dynamics, we have under-
taken structural studies of various domains of LAP2a,
alone and in complex with their known binding partners.
We here report the crystal structure of the lamin A-inter-
acting region of LAP2a, comprising residues 459–693.
RESULTS
LAP2a Is a Multimeric Protein
To investigate the ability of LAP2a to bind to other cellular
proteins, a stably transfected NIH 3T3 cell line expressing
a TAP-tagged version of murine LAP2a was established.
Western blot analysis of whole-cell lysates indicated that
TAP-LAP2a was expressed at a level similar to that of
endogenous LAP2a (Figure 2A). TAP-LAP2a that was iso-
lated from cytoplasmic extracts by using streptavidin
Sepharose and calmodulin Sepharose copurified with a
protein (Figure 2B) that was identified as endogenous
LAP2a bymass spectrometric analysis. In particular, eight
tryptic peptide fragments detected by MALDI-TOF all
matched the mouse LAP2a sequence in the NCBInr pri-
mary sequence database. Thus, cellular LAP2a is a multi-
meric protein.
The Structure of the C-Terminal Domain,
CTD, of LAP2a
As full-lengthmurine LAP2adid not have biophysical prop-
erties that allowed for experimental structure determina-
tion, we sought to identify stable and soluble fragments
by limited proteolysis. Upon chymotrypsin digestion, a
stable and soluble fragment with an apparent molecular
weight of 27 kDa, as estimated by SDS-PAGE, was
formed. Subsequent mass spectrometry and N-terminal
sequencing indicated that this fragment consisted of resi-
dues between 459 and 693, which is the native C terminus
of murine LAP2a. The fragment (denoted LAP2a-CTD)
was subcloned into pET-16b and was purified to homoge-
neity by metal affinity chromatography, followed by size-
exclusion chromatography. Crystals of LAP2a-CTD thathts reserved
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Structure of the C-Terminal Domain of LAP2adiffracted to 2.2 A˚ resolution were obtained by using vapor
diffusion, and the structure was solved with multiwave-
length anomalous diffraction (MAD) by using a Se-Met-
substituted crystal and was refined to a crystallographic
Rfree of 0.257 at 2.2 A˚ resolution (Table 1).
LAP2a-CTD forms an elongated dimer that is94 A˚ long
and 54 A˚ wide (Figure 3). In one monomer (orange in Fig-
ure 3), the current model contains amino acid residues
His465–Gly471 andPro492–Arg689. In the othermonomer
(green in Figure 3), the model contains residues His465–
Glu473, Pro489–Ser544, and Ser556–Val685. The missing
parts were disordered and did not have interpretable elec-
tron density. In the structural figures (Figures 3, 5, and 7),
the disordered loop between Ser544 and Ser556 in the
green monomer was modeled based on the conformation
of the same loop in the orangemonomer after applying the
Figure 2. Isolation of LAP2a from Stably Transfected NIH 3T3
Cells
(A) Western blot analysis of whole-cell lysates fromNIH 3T3 cells stably
transfected with TAP-LAP2a. Lane 1, molecular weight markers; lane
2, untransfected cells; lane 3, cells stably expressing TAP-LAP2a.
(B) Western blot analysis of fractions from steps during purification of
TAP-LAP2a. Lane 1, marker; lane 2, cytoplasmic extract; lane 3, flow-
through from streptavidin beads; lane 4, wash fraction from streptavi-
din beads; lane 5, proteins irreversibly bound to streptavidin beads;
lane 6, eluate from streptavidin beads; lane 7, flowthrough from cal-
modulin beads; lane 8, wash fractions from calmodulin beads; lane
9, proteins irreversibly bound to calmodulin beads; lane 10, TAP-
LAP2a eluted from calmodulin beads.Structure 15,noncrystallographic symmetry operator relating the two
monomers. In the monomer in which the loop gives rise
to interpretable electron density, the loop is stabilized by
crystal contacts. It seems likely that this is one possible
configuration from the ensemble of configurations that
exist in solution.
The interface between the monomers buries a surface
of 8110 A˚2 (Connolly, 1993) and is formed by the packing
of a pair of antiparallel a helices from each monomer to
form a left-handed, four-stranded, antiparallel coiled
coil. The characteristic side chain packing of the coiled
coil was confirmed by analyzing the refined coordinates
with SOCKET (Walshaw and Woolfson, 2001). In each
monomer, the first helix of the pair is between Glu558
and Ser605, and the second is between Asp609 and
Lys655; only a short loop separates the two helices. In the
four-helix bundle, each helix is adjacent to an antiparallel
Table 1. Diffraction and Refinement Data
Data Set Se K Edge Se Peak Se Remote
Energy (keV) 12.6587 12.6611 12.8000
Resolution (A˚) 2.2 2.2 2.2
Total reflections 143,867 286,889 142,934
Unique reflections 20,055 19,884 20,002
Completeness (%) 99.9 (100) 100 (99.9) 100.0
I/Is 7.0 (3.2) 8.4 (6.1) 8.9 (7.4)
Rsym (%) 11.2 (45.9) 13.9 (43.9) 10.0 (23.8)
Experimental Phase Determination at 2.5 A˚ Resolution
Dispersive
RCullis 0.629 0.707
RKraut 0.046 0.048
Phasing power 2.1 1.71
Anomalous
RKraut 0.066 0.016
Phasing power 2.42 2.09
Refinement (against Data Set Collected at 12.8000 keV)
Resolution (A˚) 2.2
Atoms (N) 3,096
Reflections F > 0 F/sF 19,852
R factor (%) 21.3
Rfree (%) (5% of reflections
selected randomly)
25.7
Average B factor (A˚2) 51.16
Rms DB bonded atoms (A˚2) 4.55
Rms bond lengths (A˚) 0.01
Rms bond angles () 1.38
The combined figure of merit before density modification was
0.667. Values in parentheses refer to the highest-resolution
shell between 2.26 and 2.20 A˚.643–653, June 2007 ª2007 Elsevier Ltd All rights reserved 645
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Structure of the C-Terminal Domain of LAP2aFigure 3. The LAP2a C-Terminal Domain
Is Dimeric and Contains a Four-Stranded
Coiled Coil
The six helices, A–F, are indicated for the
orange monomer. In the green monomer, the
loop between the arrows (from Ser544 to
Ser556) has been modeled based on its ob-
served conformation in the orange monomer.helix such that the two diagonally related helices in the
coiled coil are parallel to each other. Whereas second-
ary-structure prediction by PSIpred (McGuffin et al.,
2000) clearly indicated thepresenceof a longhelical region
between Thr557 and Ala641, neither COILS (Lupas et al.,
1991) norMultiCoil (Wolf et al., 1997) suggested the exten-
sive four-stranded assembly that was observed. On the
other hand, COILS did predict a short coiled-coil region
between Asp609 and Asp622 with a moderate 48% likeli-
hood. This failure in prediction is probably the result of
several unusual features in the primary sequence of the
LAP2a-CTD coiled coil that are also reflected in its three-
dimensional structure, as discussed below.
The coiled-coil region of LAP2a-CTD can be considered
in three approximately equal parts along the axis of the
coils. The bottom and top third conform to the usual fea-
tures of such assemblies (reviewed in Mason and Arndt,
2004), with arrays of mainly branched-chain hydrophobic
residues facing inward and packing in the expected
‘‘knobs-into-holes’’ manner. The situation is markedly dif-
ferent in the middle third. Here, side chains that face out
from the coiled coil are hydrophobic and pack against hy-
drophobic residues contributed by loops and other helices
that are not part of the coiled coil. Facing inward are small
hydrophobic and hydrophilic residues, creating a space
between the four helices that is occupied by five crystallo-
graphically well-defined water molecules (Figure S1; see
the Supplemental Data available with this article online).
Some of the water molecules are hydrogen bonded to
each other, and others to polar, inward-facing side chains.
Also in the middle of the coiled-coil assembly is an inti-
mate pair of carboxylates, contributed by the twoGlu634s,
that is completely buried from the solvent (Figure S1). Each
Glu634 exists in two alternate conformations, as clearly
seen in the simulated annealed omit electron density
maps. To estimate the pKa value ofGlu634, APBS calcula-646 Structure 15, 643–653, June 2007 ª2007 Elsevier Ltd All ritions (Baker et al., 2001) were carried out in two ways: one
by assuming that the second Glu634 is charged, and the
other by assuming that the second Glu634 is protonated
and therefore uncharged. This leads to an estimated pKa
value of 8.4 if the second Glu634 is charged, and 6.7 if it
is uncharged; both results are significant shifts from the
standard glutamate pKa value of 4.4. Similar pKa esti-
mates were also obtained from the PROPKA server (Li
et al., 2005a), and it therefore seems likely that both gluta-
mate residues are protonated and uncharged at neutral pH
and at an ionic strength of 150 mM.
The LAP2a-CTD fragment has six a helices, designated
A–F (Figure 4), and among these it is the fourth and the fifth
that participate in the formation of the coiled coil. Helices
A and B, the loop between them, and the loop preceding
helix C form a meandering belt that runs approximately
halfway around the coiled coil and packs against it mainly
through hydrophobic interactions. This belt between
Ser490 and Val532 contacts all four helices of the coiled
coil via hydrophobic side chain interactions, and it seems
likely that it has a stabilizing effect.
A structural homology search with DALI (Holm and
Sander, 1997) identified a number of proteins that show
significant resemblance to LAP2a-CTD. For instance, an
occludin fragment (PDB code 1wpa) (Li et al., 2005b)
has a DALI Z score of 7, with a 4.1 A˚ rms deviation over
102 equivalent residues. However, close inspection of
this and other proteins with significant DALI scores reveals
that the similarity is limited to the coiled-coil helices, heli-
ces D and E. Considering the abundance of structures
that contain a coiled-coil motif, finding similar structures
is therefore not surprising. On the other hand, the DALI
search did not identify other structures similar to LAP2a-
CTD when the remaining helices are taken into consider-
ation, indicating that LAP2a-CTD represents a previously
unseen polypeptide fold.ghts reserved
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Structure of the C-Terminal Domain of LAP2aThe observed mode of dimerization of LAP2a-CTD pro-
vides an obvious explanation of the deletion mutant re-
sults by Dechat et al. (2000) that indicated that full-length
LAP2a (1–693) was proficient in binding lamin A, but a C-
terminally deleted version (1–615) was not. The crystal
structure shows that the last 78 residues of LAP2a-CTD
(shown in red in Figure 5) include most of helix E and all
of helix F. As helix E is an integral part of the coiled-coil
motif, it is very likely that its deletion would have severely
compromised the structural integrity of the domain. Fur-
thermore, the last 78 residues include a loop between
helices E and F that may be part of the binding site for
lamin A (see below).
Each monomer of the dimer has a long loop between
residues Thr547 and Thr557 that connects helices C and
D. The two loops are entirely solvent exposed. As the ob-
served conformation of one of them is stabilized by crys-
tallographic packing interactions, it seems likely that, in
the absence of these, the loops would be disordered.
These loops border a concave surface at the bottom of
the coiled coil (in the orientation shown in Figure 3) and
are close in three-dimensional space to the loop connect-
ing helices E and F. As described below, biochemical data
suggest that these converging loops may be the binding
site for lamin A/C.
Probing the Binding between LAP2a-CTD
and Lamin A
To assess the role of various LAP2a-CTD residues in lamin
Abinding,weattempted todetect complexes betweenpu-
rified LAP2a-CTD and lamin A/C (residues 305–547) by di-
rect solution methods such as sedimentation equilibrium,
isothermal titration calorimetry, and comigration during
size-exclusion chromatography. However, we were un-
able to detect a stable complex, an observation that may
reflect the transient and weak nature of the interaction be-
tween LAP2a and lamin A. We therefore employed amod-
ified version of the solid-phase overlay assay described by
Dechat et al. (2000). His-tagged LAP2a-CTD and selected
purified point mutations were immobilized on nitrocellu-
lose membranes that were then exposed to GST-tagged
Figure 4. Amino Acid Sequence of LAP2a-CTD from Mus
musculus and Its Secondary Structure Elements
The sequence is marked at 10 residue intervals. The cylinders above
the sequence indicate helices A–F. Disordered residues in the con-
struct are shown in italics and by dashed lines. Glu634 is highlighted
in red. The 2 residues that are mutated in the construct used for struc-
tural studies are underlined.Structure 15, 6lamin A/C (305–547). The experiments were performed in
a 96-well format. Bindingwas quantitated by the detection
of bound GST-tagged lamin A/C by using an anti-GST an-
tibody. As shown in Figure 6, under the conditions used,
the binding response was linear, as blotting increasing
amounts of LAP2a-CTD led to an increase in the amount
of bound GST-tagged lamin A/C (305–547). Although the
binding assay was performed in the background of the
LAP2a-CTD R549A/I606D protein, we detected no differ-
ence in lamin A/C binding when the authentic wild-type
sequence was used.
All of the non-alanine and non-glycine residues between
Ser461 and Lys687 in LAP2a-CTD were mutated to Ala
(159 in total), with the exception of 28 residues in helices
E and F that, from their environments, appeared to be
structurally important. The mutant proteins were purified
in a high-throughput 96-well format. To control for the ob-
served variability in the amount of expressed and recov-
ered purified LAP2a-CTD proteins, parallel blots were
probed with an anti-His antibody. This was necessary
because copurifying contaminants (particularly one ob-
served reproducibly at 23 kDa) or degradation products
prevented the use of a direct measure of protein concen-
tration such as absorbance at 280 nm. The need to quan-
titate protein by use of an anti-His blot is a major source of
Figure 5. The C-Terminal Region of LAP2a Is Important for
Coiled-Coil Formation
Shown in red are the residues between 616 and 693 that are visible in
the structure.43–653, June 2007 ª2007 Elsevier Ltd All rights reserved 647
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Structure of the C-Terminal Domain of LAP2aerror in this assay, as control experiments to assess repro-
ducibility demonstrated that the standard deviation in anti-
His measurements was on the order of ±20%–30% (data
not shown).
Those point mutants that were recovered in sufficient
yield for subsequent binding experiments were analyzed
at least twice (n = 2–5). Numerous data points were
discarded because, in our initial studies, we were puzzled
to observe mutants that appeared to bind lamin A several-
fold better than wild-type. However, these invariably
corresponded to cases in which low amounts of LAP2a-
CTD were recovered, and we concluded that, under these
circumstances, the binding assay was not in the linear
range. To establish the approximate protein concentration
below which the assay was no longer reliable, for each
blot all of the anti-GST dot intensities were plotted against
Figure 6. Solid-Phase Binding Assay to Detect the Interaction
between LAP2a and Lamin A/C
(A) Top, western blot detection of purified His-tagged LAP2a-CTD;
bottom, immunodetection of GST-lamin A/C (305–547) bound to im-
mobilized LAP2a-CTD. Lane 1, LAP2a-CTD R549A/I606D; lane 2,
300 ml 10 mM lysozyme; lane 3, LAP2a-CTD I606D; lanes 4–10, (top)
0, 5, 10, 15, 20, 25, and 30 ml purified LAP2a-CTD R549A/I606D
(diluted to final volume of 200 ml); (bottom) 0, 10, 20, 30, 40, 50, and
60 ml purified LAP2a-CTD R549A/I606D (diluted to final volume of
200 ml) bound to GST-lamin A/C (305–547); lane 11, lysozyme.
(B) Graph demonstrating the linearity of the solid-phase binding assay,
as increasing amounts of LAP2a-CTD correlate to the amount of GST-
lamin A/C (305–547) detected. The points and error bars correspond to
the average and standard deviation of four replicate measurements,
respectively.
(C) Increasing amounts of LAP2a-CTD (top row) and GST-lamin A/C
(305–547) (bottom row) probed with anti-GST. There is some cross-
reactivity between LAP2a-CTD and anti-GST, accounting for 5% of
the total lamin A/C signal.648 Structure 15, 643–653, June 2007 ª2007 Elsevier Ltd All rianti-His blot intensities and the point of deviation from
linearity was estimated. Depending on the blot, between
5% and 20% of the dots appeared to fall outside of the
linear range, and these mutants were excluded from
further analysis. For six point mutants (R518A, Y519A,
R528A, M642A, L677A, and F678A), we were not able
to recover enough protein to reliably measure lamin A/
C binding. We do not know if this is an artifact of expres-
sion and purification or the result of improper protein
folding.
The lamin A/C (305–547) binding by each LAP2a-CTD
point mutant was compared to that of the unmutated pro-
tein by dividing the measured intensity of each anti-GST
‘‘dot’’ by the intensity of the corresponding anti-His ‘‘dot.’’
On each 96-well dot blot, 6 well-separated positions were
thewild-type protein, and the average value of this ratio for
the wild-type protein on each blot was used as the mea-
sure against which the point mutants on the same blot
were evaluated. Thus, a mutant LAP2a that bound less
GST-lamin A/C (305–547) than wild-type would yield an
anti-GST:anti-His ratio value less than that of wild-type.
The anti-GST:anti-His ratios for the single alanine point
mutants were averaged and compared to the average
wild-type protein ratio (normalized to 100%). The results
are shown in Table S1.
The multiple measurements on each blot for the wild-
type LAP2abinding to lamin A/C allowed for an estimate of
reproducibility. When the average wild-type anti-GST:
anti-His ratio on each blot (n = 4–6) was normalized to
100%, the average error was ±28%, ranging from ±18%
to ±39% on different blots. Thus, we considered the lamin
A/C binding by a LAP2a point mutant to be statistically
indistinguishable from that of the wild-type if it fell within
the range of 72%–128% of the wild-type value.
One striking feature of the data in Table S1 is that no sin-
gle point mutation led to the complete loss of lamin A/C
binding, suggesting that the lamin A/C-binding surface
on LAP2a is extensive and likely to involve multiple resi-
dues. Only six point mutants showed anti-GST:anti-His ra-
tios that, on a strict statistical basis, can be considered to
be different from the wild-type ratio: P492A (228% ± 89%
of wild-type; n = 3), I524A (38% ± 4%; n = 2), P548A
(66% ± 2%; n = 2), C569A (166% ± 34%; n = 3), Y572A
(70% ± 1%; n = 2), and T668A (62% ± 3%; n = 3). These
residues are shown in red and blue in Figure 7 and, with
the exception of Tyr572, which is buried, they are distrib-
uted on the bottom half of the molecular surface (in the
orientation shown in Figure 3). Although not strictly statis-
tically significant, we note two stretches of amino acids
in LAP2a-CTD that suggest a trend in altered lamin A/C
binding. These are residues 475–494 and 652–669. The
first range includes residues that have average anti-GST:
anti-His ratios greater than wild-type (and that includes
the statistically significant P492A mutant), and the latter
has an extended stretch of residues with average anti-
GST:anti-His ratios less than wild-type (and that includes
T668A). Both regions feature flexible loops that might be
expected to be characteristic of protein-protein inter-
faces: residues 475–494 coincide almost precisely withghts reserved
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Structure of the C-Terminal Domain of LAP2aFigure 7. Site-Directed Mutations in the
LAP2a C-Terminal Domain Affect Lamin
A/C Binding
Shown in red are the residues that are compro-
mised in lamin A/C binding when mutated to
Ala; shown in blue are those that have en-
hanced lamin A/C binding. The region compris-
ing residues 652–669 is shown in orange and
may form part of the lamin A/C-binding site.the disordered region in the N terminus of the construct
following the first helix, whereas residues 652–669 are part
of the concave surface located at one end of the coiled coil
(the bottom, in the orientation shown in Figure 3).
The last visible residue at the C terminus of LAP2a-CTD
is Lys688. The final 5 residues at the C terminus are disor-
dered and include the residue implicated in one family with
dilated cardiomyopathy, R690C (Taylor et al., 2005). We
generated the equivalent murine R689C LAP2a-CTD
mutation and tested it for lamin A/C (305–547) binding. Al-
though we did not detect a loss of lamin A/C (305–547)
binding (as shown in Table S1), we cannot rule out the
possibility that, when using full-length LAP2a produced
in a reticulocyte-based in vitro translation system, re-
duced binding would have been detected under the pull-
down assay conditions described by Taylor et al. (2005).
DISCUSSION
The structure of LAP2a-CTD presented here provides in-
sight into the structural organization and the multimeriza-
tion of this lamin-binding protein. One prominent feature of
the structure is a central, four-stranded coiled coil arising
as a consequence of dimerization. Coiled coils are often
seen in protein structures and, by one estimate, account
for 3% of all protein substructure (Wolf et al., 1997).
The existence of coiled coils was predicted by Francis
Crick (Crick, 1952) to explain a characteristic 5.1 A˚ reflec-
tion in the X-ray diffraction pattern of a-keratin decades
before the first direct crystallographic observation of a
coiled coil (O’Shea et al., 1991).
The coiled coil formed by LAP2a-CTD is unusual as it
contains a space in its center section that has inward-
pointing polar residues and a number of water molecules.
Two buried glutamate residues are also located in this
space. While buried residues of like charge in each other’s
proximity are infrequently observed in coiled-coil struc-
tures, they have been encountered in a number of casesStructure 15,in which they have been suggested to contribute to both
specificity and stability (Burkhard et al., 2001). In certain
instances, closely located buried glutamates have been
shown to act as pH-dependent conformational switches.
One well-known example is influenza hemagglutinin, in
which two glutamates together with a histidine act in such
amanner (Bullough et al., 1994). More recently, it has been
shown that four buried glutamates in TraM, a bacterial F
plasmid conjugation protein that contains a four-stranded,
parallel coiled coil, serve as pH-dependent conforma-
tional switches (Lu et al., 2006). While we have no evi-
dence that the buried Glu634 residues in LAP2a-CTD play
such a role, their unusual location and their conservation
among available LAP2a sequences is intriguing.
A body of in vitro and cell culture work has implicated
LAP2a in several overlapping cellular pathways due to
its demonstrated ability to bind BAF, lamin A/C, the retino-
blastoma protein, and chromatin. The ability of LAP2a to
interact with lamin A is its eponymous cellular function. It
hasbeenpreviously shown that LAP2aand laminA interact
directly and colocalize during specific periods of the cell
cycle (Dechat et al., 1998). We employed a solid-phase
overlay assay to characterize the contributions of surface
residues of LAP2a to lamin A/C binding, and to identify
two surface regions of LAP2a that may be involved in the
lamin A/C interaction. In our assay, we used a minimal
lamin A/C construct, residues 305–547, which contains
two previously structurally characterized domains. Lamin
A/C residues 305–386 form a dimeric coiled coil (Strelkov
et al., 2004), whereas residues 430–550 form a globular
domain with an immunoglobulin-like fold (Krimm et al.,
2002; Dhe-Paganon et al., 2002). Using our assay, we
were unable to detect binding between LAP2a-CTD and
a GST fusion protein consisting only of lamin residues
305–386 (data not shown), suggesting that either a combi-
nation of the two domains is required, or the region
from 389 to 547 is sufficient for binding. As one of the
main biological roles of immunoglobulin-like domains is643–653, June 2007 ª2007 Elsevier Ltd All rights reserved 649
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the latter possibility is more likely.
LAP2a has been shown to bind to hypophosphorylated
Rb, possibly in the context of a larger complex that in-
cludes lamin A/C (Markiewicz et al., 2002; Dorner et al.,
2006). In cell culture, modulating the levels of LAP2a either
by overexpression or RNAi leads to measurable effects
on proliferation and cell-cycle progression, most likely
through amechanism operating at the G1/ S phase tran-
sition (Dorner et al., 2006). As Rb is responsible for a major
G1 checkpoint (reviewed in Giacinti and Giordano, 2006),
the idea has been forwarded that a complex involving
LAP2a may be important in differentiation in certain cell
types. Binding studies have demonstrated that the region
in LAP2a involved in binding Rb is contained within resi-
dues 415–615 (Dorner et al., 2006). Since the bulk of this
region is represented in the structure of LAP2a-CTD, it is
now possible to rationally test the role of specific residues
or regions on the surface on LAP2a in the Rb interaction. It
is important to note that while deletion analysis has
defined the regions in LAP2a responsible for Rb binding
(residues 415–615) and lamin A/C binding (residues 616–
693) as sequential in primary sequence, the structure of
LAP2a-CTD reveals that these two regions are intertwined
and part of a single structural domain.
The chromatin interaction domain of LAP2a has been
established by deletion analysis to consist of residues
270–615 (Vlcek et al., 1999). This interaction is distinct
from thatmediated through the binding of the LEMdomain
to BAF, a nonspecific DNA-binding protein (Zheng et al.,
2000). It has been reported that, during apoptosis, LAP2a
is cleaved in a caspase-dependent manner into N- and C-
terminal fragments in which the C-terminal fragment is
28 kDa (Gotzmann et al., 2000), very similar in size to
our proteolytically defined LAP2a-CTD. Consistent with
this, a potential caspase-cleavage site is present at resi-
due 440, just upstream of the beginning of the construct
used in this work. Neither the N- nor the C-terminal frag-
ment of LAP2a generated by caspase cleavage binds
chromosomes (Gotzmann et al., 2000), suggesting that
LAP2a-CTD is not sufficient for chromosome association,
and that some combination of this domain and upstream
regions of LAP2a is needed.
The structure of LAP2a-CTD establishes that the physi-
ological form of the protein is at least a dimer. It has re-
cently been reported that LAP2a is trimeric, a conclusion
based on the results of crosslinking analysis, seminative
PAGE, and size-exclusion chromatography (Snyers et al.,
2007). Although this would seem to be at odds with the
structural result presented here, it is possible that the dis-
crepancy is one of interpretation. For example, we note
that LAP2a migrates slower on polyacrylamide gels than
expected for its molecular weight (as seen in Figure 2A),
and that the reported estimated molecular mass of 207
kDa (Snyers et al., 2007) is a value between that of a theo-
retical dimer (151 kDa) and a trimer (226 kDa). However,we
cannot formally rule out that the independently expressed
LAP2a-CTD forms a different assembly than full-length
LAP2a.650 Structure 15, 643–653, June 2007 ª2007 Elsevier Ltd All rigThe observation that LAP2a forms a multimer provides
an elegant structural explanation for the intriguing obser-
vation that a His-tagged form of LAP2a 1–186 is unable
to interact with chromosomes in vitro, whereas theGST fu-
sion version interacts specifically with chromosomal DNA
(Vlcek et al., 1999). It seems that GST, an obligate dimer,
is able to pair the monomeric N-terminal ‘‘constant
domain’’ of LAP2a to recapitulate the role of the four-
stranded coiled coil of LAP2a-CTD. The ability to pair, or
to bring into close proximity, N-terminal constant domains
is consistent with the antiparallel arrangement of LAP2a-
CTD that dictates that the upstream amino acids are on
the same end of the coiled coil (i.e., the amino termini of
the two monomers in the LAP2a-CTD dimer are on the
same end of the coiled coil, not opposing ones). It has
also been suggested that the overall architecture of
LAP2a might be considered as a series of independent
structural modules akin to ‘‘beads on a string’’ (Cai et al.,
2001). The structure of LAP2a-CTD supports such a pro-
posal, in the sense that we have provided a viewof the final
C-terminal module. However, the finding that LAP2a-CTD
is a dimer requires that the analogy be modified such that
LAP2a is viewed, minimally, as a double-stranded neck-
lace of beads.
The complexity of the network of interactions involving
lamin A/C has prevented a simple and clear picture of its
precise role, or roles, during normal cellular processes.
However, the existence of debilitating laminopathies in
which lamin A/C structure or processing is affected is
proof of their importance. Many of the point mutations in
laminopathies fall in the region involved in the binding of
lamin A/C to LAP2a (Broers et al., 2006). Understanding
this interaction in atomic detail, and other interactions in
which LAP2a takes part, is an important future goal toward
understanding the effects of these mutations on disease
progression.
EXPERIMENTAL PROCEDURES
Pull-Down Assay for Cellular LAP2a
The cDNA encoding full-length mouse LAP2a was cloned into the
EcoRV site of pCTAP mammalian expression vector (InterPlay Mam-
malian TAP System, Stratagene). The vector expressing tandem tag-
fused LAP2a (TAP-LAP2a) was digested with ApaLI to linearize the
plasmid DNA and was transfected into NIH 3T3 cells by the calcium
phosphate transfection method. To establish stable TAP-LAP2a-
expressing cells, the transfected cells were selected and maintained
in culture medium (Dulbecco’s modified Eagle’s medium, 10% fetal
calf serum, high glucose, sodium pyruvate, GlutaMAX [Invitrogen],
100 U/ml penicillin, 100 mg/ml streptomycin) containing 600 mg/ml ge-
neticin (Invitrogen). Cytoplasmic extract (5 ml) was isolated from 1 3
108 of the stable cell line with buffer A (20 mM HEPES-NaOH [pH
7.5], 5 mMMgCl2, 150 mM KCl, 10 mM DTT) containing 0.05% digito-
nin (Sigma) and protease inhibitors (1 mM PMSF, 20 mg/ml aprotinin,
2 mg/ml leupeptin, 2 mg/ml pepstatin). The extract was mixed with
2 mM EDTA and 10 mM b-mercaptoethanol (bME) and then incubated
at 4C for 4 hr with 500 ml streptavidin Sepharose HP beads (GE
Healthcare) equilibrated with buffer A. Beads were washed with 40 ml
buffer B (buffer A containing 0.1% NP40, 2 mM EDTA, 10 mM bME,
and protease inhibitors), and TAP-LAP2a protein was eluted with 1
ml buffer B containing 2 mM D-biotin (Sigma). Eluted sample was
mixed with 2 mM CaCl2 and 4 ml buffer C (20 mM Tris-HCl [pH 8.0],hts reserved
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NP40, 10 mM bME) and then incubated in the presence of protease in-
hibitors at 4C for 2 hr with 250 ml calmodulin Sepharose 4B beads (GE
Healthcare) equilibrated with buffer C. Beads were washed with 40 ml
buffer C, and TAP-LAP2a protein was eluted with 1 ml buffer C con-
taining 20 mM EGTA instead of CaCl2. The final sample was concen-
trated and subjected to immunoblotting with a NuPAGE 4%–12%
Bis-Tris gel and the WesternBreeze chemiluminescent immunodetec-
tion kit (Invitrogen). The primary antibody used for the immunoblotting
was anti-LAP2 mouse monoclonal IgG (Clone 27, BD Transduction
Laboratories). Endogenous LAP2a and TAP-LAP2a were detected
by a luminescence image analyzer, LAS 1000 (Fujifilm).
Mass Spectrometric Analysis
The protein band copurifying with TAP-LAP2a was visualized by Coo-
massie blue stain and excised. The gel slices were extensively de-
stained in 50% methanol/10% acetic acid. SDS was removed by
two 10 min washes with 50 mM NH4HCO3. The gel slice was then de-
hydrated with 100% acetonitrile, vacuum desiccated, and exposed to
0.5 mg trypsin in 50mMNH4HCO3 buffer at room temperature for 16 hr.
The supernatant was recovered and subjected to mass spectrometric
(MS) analysis. MS spectra of tryptic fragments were recorded with the
Kratos Axima-CFR MALDI-TOF instrument with a-cyano-4-hydroxy-
cinnamic acid as the matrix. The obtained data and the Mascot search
engine (http://www.matrixscience.com) were used to identify the pep-
tide peaks from the NCBInr primary sequence database.
Protein Expression and Purification for Crystallography
The coding region corresponding to murine LAP2a residues 459–693
was cloned into pET-16b. A point mutation of Arg549 to Ala was intro-
duced by using the QuikChange (Stratagene) method to prevent the
observed efficient cleavage between Arg549 and Ala550 by Factor
Xa. A second point mutation, I606D, the human amino acid at this
position, was inadvertently introduced, and, unless otherwise stated,
‘‘LAP2a-CTD’’ refers to residues 459–693 with these two point
mutations.
E. coli BL21(DE3) cells expressing His-tagged LAP2a-CTD were
grown at 37C until OD600 reached 0.6–1.0, and then induced with
IPTG to a final concentration of 1 mM. After 5 hr at 37C, the cells
were harvested, resuspended in 50 mM Tris (pH 8.0), 0.5 M NaCl,
5 mM imidazole (lysis buffer), and stored at 80C prior to use. To pu-
rify LAP2a-CTD, cells were thawed, and the volume was raised to
50 ml per liter of cells by using lysis buffer. bME was added to bring
the concentration to 5 mM, and one Complete Protease Inhibitor
(EDTA free) tablet (Roche Scientific) was added per 50ml resuspended
cells. Cells were lysed by using a microfluidizer and centrifuged, and
the supernatant was loaded onto a 15 ml Ni-NTA column equilibrated
in lysis buffer. The column was washed extensively in steps with lysis
buffer + 20 mM imidazole and lysis buffer + 60 mM imidazole, and the
protein was then eluted by using a gradient from 60 mM to 500 mM
imidazole into fraction tubes containing EDTA such that the final con-
centration was 10 mM EDTA.
Fractions containing LAP2a-CTD were combined, and the protein
concentration was estimated by using 3 = 18,140 M1 cm1. Factor
Xa (NEB) was added to a final concentration of 1% (w/w), and the so-
lution was dialyzed at 4Cagainst 25mMsodium citrate (pH 5.0), 0.5M
NaCl, 1 mM EDTA, 5 mM bME until the cleavage was complete, as as-
sessed by SDS-PAGE (36 hr). The protein was concentrated to less
than 15 ml and was loaded onto a HiLoad Superdex 75 26/60 column
(GE Amersham) equilibrated in dialysis buffer. Fractions containing
LAP2a-CTD were concentrated to 8 mg/ml and redialyzed against di-
alysis buffer prior to crystallization. The final yield of purified protein
was 20 mg per liter of cells.
Crystallography and Structure Determination
Crystals were obtained by using hanging-drop vapor-diffusion by mix-
ing 4 ml protein with an equal volume of a well solution containing 25%
(w/v) PEG-3000, 0.1 M MES (pH 6.5), 10 mM Tris (pH 8.5), and 5 mMStructure 15bME. Crystals were transferred rapidly to paratone and were flash fro-
zen in a cold nitrogen stream operating at 95 K. Crystals were ortho-
rhombic, in space group P212121, and had unit cell parameters of
a = 55.1, b = 55.7, and c = 122.9 A˚; there was one dimer in the asym-
metric unit. Multiwavelength anomalous diffraction (MAD) data were
collected at ID-22 at the Advanced Photon Source at three X-ray ener-
gies around the K absorption edge of Se. Data were collected at 100 K
and were recorded on a MAR300 mosaic CCD detector. The relatively
large size of the crystal (800 mm) allowed it to be translated several
times during data collection relative to the direct beam that was slitted
down to 100 mm, in order to avoid radiation damage. Diffraction data
were processed with the HKL2000 suite (Otwinowski and Minor,
1997). Fa coefficients from the MAD data set were estimated with
XPREP (Bruker, Inc.), and all six Se positions were found by using
these coefficients in SHELXD (Sheldrick, 1998). The positional and
thermal parameters of the Se atoms were refined with phase-integrat-
ing least-squares at 2.5 A˚ resolution with PHASES (Furey and Swami-
nathan, 1997). PHASESwas also used to compute the final experimen-
tal electron density map after solvent flattening and real-space
noncrystallographic symmetry averaging at 2.5 A˚ resolution. The
map was interpreted manually by using O (Jones et al., 1991), and
the structural model was refined by using cartesian molecular dynam-
ics, energy minimization, and restrained atomic displacement param-
eter refinement with the OpenMP version of CNX2005 at 2.2 A˚ resolu-
tion. The lowest Rfree values were achieved without the use of
noncrystallographic symmetry restraints. At the end of the refinement,
59 water molecules were added. The Ramachandran plot has 89.7%
of all residues in the most favored regions. One residue, Ser523 of
one of the chains, is in the disallowed region and is involved in a crys-
tal-packing interaction. Simulated annealed omit electron density is
consistent with the model for this residue, and there is no significant
positive or negative difference density around it.
Solid-Phase Overlay Binding Assay
Expression and Purification of LAP2a-CTD Point Mutants
Single alanine point mutations were introduced into the pET-16b-
derived vector expressing LAP2a-CTD R549A/I606D by using the
QuikChange method (Stratagene), and the mutations were confirmed
by DNA sequencing. LAP2a-CTD and the mutant proteins were each
expressed in BL21(DE3) pLysS cells (Novagen) in 5 ml LB broth (KD
Medical) containing 50mg/ml carbenicillin and 34mg/ml chloramphenicol
in 24-well blocks. When OD600 reached 0.8–0.9 for one well of cells ex-
pressing LAP2a-CTD R549A/I606D, all wells were induced by the ad-
dition of IPTG to a final concentration of 0.8 mM. After 5.5 hr at 20C,
cells were spun down, and the supernatants were removed. The Robo-
Pop Ni-NTA His-Bind Purification Kit (Novagen) was used with slight
modifications to the manufacturer’s protocol. Briefly, cells were resus-
pended in 500 ml binding buffer (300 mM NaCl, 50 mM Na3PO4, 2 mM
bME) containing 10 mM imidazole and were lysed by the addition of
500 ml Pop Culture Reagent and 5 ml (125U) Benzonase, followed by in-
cubation with gentle mixing at room temperature for 10 min. Ni-NTA
His Bind Resin (500 ml) that had beenwashed and diluted 1:1 with bind-
ing buffer containing 10 mM imidazole was added, and the mixture
was incubated at room temperature for 5 min. After transfer to a 96-
well filter plate, the resin was washed four times with 500 ml binding
buffer containing 125 mM imidazole and twice with 500 ml binding
buffer containing 250 mM imidazole. The proteins were then eluted
into a 96-well collection plate by using 2 3 150 ml binding buffer con-
taining 800 mM imidazole. The proteins were stored at 4C after addi-
tion of 1 ml 1.43 M bME to each well and were used within 2 weeks of
purification.
Expression and Purification of Lamin A, 305–547
Using the QuikChange Multi-Site Kit (Stratagene), six point mutations
(T409S, T424S, K470R, L479M, A500S, and N524S) were introduced
into human lamin A (305–547) to convert it to mouse lamin A; the mu-
tations were confirmed by DNA sequencing. The lamin A (305–547) re-
gion was then amplified by PCR and ligated into the pGEX-6P-1 vector
(GE Healthcare) by using the BamHI and XhoI sites. The GST fusion, 643–653, June 2007 ª2007 Elsevier Ltd All rights reserved 651
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in LB broth (KD Medical) containing 75 mg/ml carbenicillin until the
OD600 reached 0.8–0.9, then induction with IPTG (final concentration
of 0.5 mM) for 2.5 hr at 37C. Cells were harvested, resuspended in
23PBS (pH 7.4), and stored at80Cprior to use. To purify GST-lamin
A (305–547), thawed cells were diluted 1:1 (v/v) with 13 PBS (pH 7.4), 5
mM DTT and sonicated, and the supernatant obtained upon centrifu-
gation was loaded onto a GSTrap column (GE Healthcare) equilibrated
in 13 PBS (pH 7.4), 5 mM DTT. The column was washed in the same
buffer, and GST-lamin A (305–547) was eluted by using 50 mM Tris
(pH 7.5), 10 mM glutathione. Fractions containing the fusion protein
were combined and dialyzed overnight against 50 mM Tris (pH 7.5),
150 mM NaCl, 1 mM EDTA, and 1 mM DTT. Purified GST-lamin A
(305–547) was stored at 4C and used within 2 weeks of purification.
Solid-Phase Overlay Assay
The relative amounts of the purified LAP2a-CTD mutant proteins were
established by western blot analysis with an anti-His antibody (GE
Healthcare). Briefly, purified proteins were blotted onto nitrocellulose
(0.2 mm; Schleicher and Schuell, Inc.) in 300 mM NaCl, 50 mM
Na3PO4, 10 mM imidazole (pH 8.0) by using the Bio-Dot System (Bio-
Rad). Membranes were then blocked, incubated with primary anti-
body, washed, and incubated with secondary anti-mouse antibody
conjugated to alkaline phosphatase. The WesternBreeze chemilumi-
nescent immunodetection system (Invitrogen) was used for immuno-
detection of the His-tagged proteins.
To measure binding between the purified LAP2a-CTD proteins and
GST-lamin A (305–547), LAP2a-CTD alanine mutants and the wild-
type were blotted onto nitrocellulose as described above. After block-
ing, the membranes were incubated for 3 hr at room temperature with
2 mM GST-lamin A (305–547) in Blocking Solution. Membranes were
blocked again and incubated overnight with primary antibody (anti-
GST from GE Healthcare). The WesternBreeze anti-goat chemilumi-
nescent immunodetection system (Invitrogen) was then used for
immunodetection of the GST fusion proteins by following themanufac-
turer’s protocol. Dot intensities were quantitated by using the Chem-
iImager 5500 1-D Multi analysis tool (Alpha Innotech).
Supplemental Data
Supplemental Data include a stereo image that shows details of the
coiled coil around the bulge region and a table that contains the results
of the binding assay between LAP2a-CTD alanine point mutants and
lamin A (305–547) and are available at http://www.structure.org/cgi/
content/full/15/6/643/DC1/.
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